November 8, 2017 / 9:14 PM / a month ago

BRIEF-Cascadian Therapeutics reports Q3 loss per share $0.28

Nov 8 (Reuters) - Cascadian Therapeutics Inc:

* Cascadian Therapeutics reports third quarter 2017 financial results

* Q3 loss per share $0.28

* Q3 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S

* Cascadian therapeutics - ‍ cash, cash equivalents and investments totaled $113.0 million as of Sept 30, 2017, compared to $62.8 million at Dec 31, 2016​

* Cascadian Therapeutics Inc - ‍ cash used in operations for 2017 is expected to be approximately $50.0 million to $54.0 million​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below